-
Tencent Invests USD 30 Million in Early Cancer Detection Firm Insighta, Backed by Prenetics
•
Prenetics Global Limited (NASDAQ: PRE), a prominent health sciences company with operations in the US and Hong Kong, China, has announced a significant investment of USD 30 million by Chinese internet conglomerate Tencent into Insighta, a Hong Kong-based company specializing in early cancer detection. Insighta represents a substantial joint venture…
-
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
•
Hong Kong-based Prenetics Global Ltd (NASDAQ: PRE) has announced the acquisition of a majority stake in Taiwan-based ACT Genomics Holdings Co., Ltd, aiming to establish a powerhouse Asia-based genomics and precision oncology firm. The transaction involves a USD 20 million cash payment and the issuance of 19.9 million common Prenetics…
